IL105553A - Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water - Google Patents

Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water

Info

Publication number: IL105553A
Authority: IL; Israel
Prior art keywords: dosage form; solvent; form according; matrix material; matrix
Prior art date: 1992-05-06

Application number

IL105553A

Other languages

English (en)

Hebrew (he)

Other versions

IL105553A0 (en

Original Assignee

Janssen Pharmaceutica Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-06

Filing date

1993-04-29

Publication date

1998-01-04

1993-04-29 Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc

1993-08-18 Publication of IL105553A0 publication Critical patent/IL105553A0/xx

1998-01-04 Publication of IL105553A publication Critical patent/IL105553A/en

Links

239000011159 matrix material Substances 0.000 title claims abstract description 65
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims description 41
239000000463 material Substances 0.000 title claims description 23
239000007909 solid dosage form Substances 0.000 title abstract description 9
108010010803 Gelatin Proteins 0.000 claims abstract description 20
229920000159 gelatin Polymers 0.000 claims abstract description 20
235000019322 gelatine Nutrition 0.000 claims abstract description 20
235000011852 gelatine desserts Nutrition 0.000 claims abstract description 20
239000001814 pectin Substances 0.000 claims abstract description 19
235000010987 pectin Nutrition 0.000 claims abstract description 19
229920001277 pectin Polymers 0.000 claims abstract description 19
239000008273 gelatin Substances 0.000 claims abstract description 18
150000001413 amino acids Chemical class 0.000 claims abstract description 16
101710145505 Fiber protein Proteins 0.000 claims abstract description 11
125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
239000002552 dosage form Substances 0.000 claims description 76
239000000203 mixture Substances 0.000 claims description 52
239000003795 chemical substances by application Substances 0.000 claims description 35
238000004108 freeze drying Methods 0.000 claims description 27
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 26
239000013543 active substance Substances 0.000 claims description 24
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 20
229930195725 Mannitol Natural products 0.000 claims description 20
239000000594 mannitol Substances 0.000 claims description 20
235000010355 mannitol Nutrition 0.000 claims description 20
229940024606 amino acid Drugs 0.000 claims description 15
238000004090 dissolution Methods 0.000 claims description 14
239000004471 Glycine Substances 0.000 claims description 13
235000010469 Glycine max Nutrition 0.000 claims description 11
239000007787 solid Substances 0.000 claims description 11
239000004480 active ingredient Substances 0.000 claims description 9
229920000858 Cyclodextrin Polymers 0.000 claims description 6
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 6
235000014113 dietary fatty acids Nutrition 0.000 claims description 6
239000000194 fatty acid Substances 0.000 claims description 6
229930195729 fatty acid Natural products 0.000 claims description 6
150000004665 fatty acids Chemical group 0.000 claims description 6
125000005456 glyceride group Chemical group 0.000 claims description 6
235000000346 sugar Nutrition 0.000 claims description 6
229920002125 Sokalan® Polymers 0.000 claims description 5
239000006260 foam Substances 0.000 claims description 5
229920001285 xanthan gum Polymers 0.000 claims description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
229930182844 L-isoleucine Natural products 0.000 claims description 4
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
239000011248 coating agent Substances 0.000 claims description 4
229940097362 cyclodextrins Drugs 0.000 claims description 4
239000008121 dextrose Substances 0.000 claims description 4
229930182830 galactose Natural products 0.000 claims description 4
229960000310 isoleucine Drugs 0.000 claims description 4
235000010493 xanthan gum Nutrition 0.000 claims description 4
239000000230 xanthan gum Substances 0.000 claims description 4
229940082509 xanthan gum Drugs 0.000 claims description 4
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
239000008101 lactose Substances 0.000 claims description 3
239000002245 particle Substances 0.000 claims description 3
229960005190 phenylalanine Drugs 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 3
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
239000002253 acid Substances 0.000 claims 2
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
239000002904 solvent Substances 0.000 description 112
238000000034 method Methods 0.000 description 37
239000000243 solution Substances 0.000 description 31
239000000523 sample Substances 0.000 description 26
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
238000002360 preparation method Methods 0.000 description 15
239000003814 drug Substances 0.000 description 14
239000006185 dispersion Substances 0.000 description 13
239000007788 liquid Substances 0.000 description 13
239000000047 product Substances 0.000 description 13
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 12
238000003756 stirring Methods 0.000 description 11
239000000725 suspension Substances 0.000 description 11
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
235000001014 amino acid Nutrition 0.000 description 10
238000007711 solidification Methods 0.000 description 10
230000008023 solidification Effects 0.000 description 10
229940079593 drug Drugs 0.000 description 9
239000000902 placebo Substances 0.000 description 9
239000000796 flavoring agent Substances 0.000 description 8
235000019634 flavors Nutrition 0.000 description 8
238000007710 freezing Methods 0.000 description 8
230000008014 freezing Effects 0.000 description 8
239000007789 gas Substances 0.000 description 8
229960002989 glutamic acid Drugs 0.000 description 8
229940068196 placebo Drugs 0.000 description 8
108010011485 Aspartame Proteins 0.000 description 7
239000000605 aspartame Substances 0.000 description 7
235000010357 aspartame Nutrition 0.000 description 7
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 7
229960003438 aspartame Drugs 0.000 description 7
239000012867 bioactive agent Substances 0.000 description 7
-1 cyclic sugars Chemical class 0.000 description 7
238000009472 formulation Methods 0.000 description 7
238000011068 loading method Methods 0.000 description 7
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 6
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
239000012876 carrier material Substances 0.000 description 6
238000005336 cracking Methods 0.000 description 6
238000001035 drying Methods 0.000 description 6
230000002209 hydrophobic effect Effects 0.000 description 6
239000008213 purified water Substances 0.000 description 6
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
229960003767 alanine Drugs 0.000 description 5
238000010438 heat treatment Methods 0.000 description 5
229910052757 nitrogen Inorganic materials 0.000 description 5
239000000843 powder Substances 0.000 description 5
239000000126 substance Substances 0.000 description 5
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 4
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 4
235000013922 glutamic acid Nutrition 0.000 description 4
239000004220 glutamic acid Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 3
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
239000004395 L-leucine Substances 0.000 description 3
235000019454 L-leucine Nutrition 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
229960005261 aspartic acid Drugs 0.000 description 3
238000009835 boiling Methods 0.000 description 3
229940046978 chlorpheniramine maleate Drugs 0.000 description 3
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 3
235000013305 food Nutrition 0.000 description 3
229960001680 ibuprofen Drugs 0.000 description 3
229960003136 leucine Drugs 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
229960005489 paracetamol Drugs 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
238000000859 sublimation Methods 0.000 description 3
230000008022 sublimation Effects 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
229920001817 Agar Polymers 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000209140 Triticum Species 0.000 description 2
235000021307 Triticum Nutrition 0.000 description 2
239000008272 agar Substances 0.000 description 2
235000010419 agar Nutrition 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000002775 capsule Substances 0.000 description 2
235000011089 carbon dioxide Nutrition 0.000 description 2
235000010418 carrageenan Nutrition 0.000 description 2
229920001525 carrageenan Polymers 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000011978 dissolution method Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000003337 fertilizer Substances 0.000 description 2
235000013312 flour Nutrition 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000037406 food intake Effects 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
229960002449 glycine Drugs 0.000 description 2
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000002917 insecticide Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
238000002844 melting Methods 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
239000003973 paint Substances 0.000 description 2
239000008177 pharmaceutical agent Substances 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
229960003908 pseudoephedrine Drugs 0.000 description 2
229960003447 pseudoephedrine hydrochloride Drugs 0.000 description 2
BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
230000009747 swallowing Effects 0.000 description 2
229920001059 synthetic polymer Polymers 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
VCTHNOIYJIXQLV-UHFFFAOYSA-N 1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;hydron;dichloride Chemical compound Cl.Cl.CC1=CC=CC(CN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 VCTHNOIYJIXQLV-UHFFFAOYSA-N 0.000 description 1
QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
244000247812 Amorphophallus rivieri Species 0.000 description 1
235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
244000303965 Cyamopsis psoralioides Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
108010082495 Dietary Plant Proteins Proteins 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
239000001116 FEMA 4028 Substances 0.000 description 1
RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
108010068370 Glutens Proteins 0.000 description 1
229920002907 Guar gum Polymers 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
229920002752 Konjac Polymers 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
229920000161 Locust bean gum Polymers 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
DYWNLSQWJMTVGJ-KUSKTZOESA-N Phenylpropanolamine hydrochloride Chemical compound Cl.C[C@H](N)[C@H](O)C1=CC=CC=C1 DYWNLSQWJMTVGJ-KUSKTZOESA-N 0.000 description 1
244000090599 Plantago psyllium Species 0.000 description 1
235000010451 Plantago psyllium Nutrition 0.000 description 1
229920001100 Polydextrose Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004365 Protease Substances 0.000 description 1
235000011034 Rubus glaucus Nutrition 0.000 description 1
244000235659 Rubus idaeus Species 0.000 description 1
235000009122 Rubus idaeus Nutrition 0.000 description 1
244000061456 Solanum tuberosum Species 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
235000009754 Vitis X bourquina Nutrition 0.000 description 1
235000012333 Vitis X labruscana Nutrition 0.000 description 1
240000006365 Vitis vinifera Species 0.000 description 1
235000014787 Vitis vinifera Nutrition 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
229940057282 albuterol sulfate Drugs 0.000 description 1
BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
239000007961 artificial flavoring substance Substances 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
150000001557 benzodiazepines Chemical class 0.000 description 1
WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
235000011175 beta-cyclodextrine Nutrition 0.000 description 1
229960004853 betadex Drugs 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000000679 carrageenan Substances 0.000 description 1
229940113118 carrageenan Drugs 0.000 description 1
HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
238000000576 coating method Methods 0.000 description 1
238000004040 coloring Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000000039 congener Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
229960003529 diazepam Drugs 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
229960004993 dimenhydrinate Drugs 0.000 description 1
MZDOIJOUFRQXHC-UHFFFAOYSA-N dimenhydrinate Chemical compound O=C1N(C)C(=O)N(C)C2=NC(Cl)=N[C]21.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 MZDOIJOUFRQXHC-UHFFFAOYSA-N 0.000 description 1
AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
239000003651 drinking water Substances 0.000 description 1
235000020188 drinking water Nutrition 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000005188 flotation Methods 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
235000021312 gluten Nutrition 0.000 description 1
230000005484 gravity Effects 0.000 description 1
235000010417 guar gum Nutrition 0.000 description 1
239000000665 guar gum Substances 0.000 description 1
229960002154 guar gum Drugs 0.000 description 1
229960003878 haloperidol Drugs 0.000 description 1
238000003898 horticulture Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
239000000252 konjac Substances 0.000 description 1
235000010485 konjac Nutrition 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
235000010420 locust bean gum Nutrition 0.000 description 1
239000000711 locust bean gum Substances 0.000 description 1
229960004391 lorazepam Drugs 0.000 description 1
238000012792 lyophilization process Methods 0.000 description 1
239000000391 magnesium silicate Substances 0.000 description 1
229940099273 magnesium trisilicate Drugs 0.000 description 1
229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
235000019793 magnesium trisilicate Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000000155 melt Substances 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000000051 modifying effect Effects 0.000 description 1
230000003232 mucoadhesive effect Effects 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229940055729 papain Drugs 0.000 description 1
229960002305 phenylpropanolamine hydrochloride Drugs 0.000 description 1
235000013856 polydextrose Nutrition 0.000 description 1
229940068917 polyethylene glycols Drugs 0.000 description 1
239000010318 polygalacturonic acid Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
238000005086 pumping Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
229940083037 simethicone Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229940079832 sodium starch glycolate Drugs 0.000 description 1
239000008109 sodium starch glycolate Substances 0.000 description 1
229920003109 sodium starch glycolate Polymers 0.000 description 1
239000012265 solid product Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
230000003685 thermal hair damage Effects 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Polymers & Plastics (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Mechanical Engineering (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL105553A 1992-05-06 1993-04-29 Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water IL105553A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US87975492A	1992-05-06	1992-05-06

Publications (2)

Publication Number	Publication Date
IL105553A0 IL105553A0 (en)	1993-08-18
IL105553A true IL105553A (en)	1998-01-04

Family

ID=25374827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL105553A IL105553A (en)	1992-05-06	1993-04-29	Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water

Country Status (28)

Country	Link
EP (1)	EP0642334B1 (zh)
JP (1)	JPH07508019A (zh)
KR (1)	KR100194241B1 (zh)
CN (1)	CN1085081A (zh)
AT (1)	ATE183387T1 (zh)
BG (1)	BG62681B1 (zh)
CA (1)	CA2135062C (zh)
CL (1)	CL2004001180A1 (zh)
CY (1)	CY2175B1 (zh)
CZ (1)	CZ283882B6 (zh)
DE (1)	DE69326063T2 (zh)
DK (1)	DK0642334T3 (zh)
ES (1)	ES2136662T3 (zh)
FI (1)	FI111333B (zh)
GR (1)	GR3031180T3 (zh)
HK (1)	HK1010693A1 (zh)
HU (2)	HU227532B1 (zh)
IL (1)	IL105553A (zh)
MY (1)	MY112231A (zh)
NO (1)	NO308065B1 (zh)
NZ (1)	NZ252526A (zh)
PL (1)	PL172354B1 (zh)
RO (1)	RO112990B1 (zh)
RU (1)	RU2131244C1 (zh)
SG (1)	SG47430A1 (zh)
SK (1)	SK280129B6 (zh)
TW (1)	TW380053B (zh)
WO (1)	WO1993023017A1 (zh)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5582591A (en) *	1994-09-02	1996-12-10	Delab	Delivery of solid drug compositions
US5837276A (en) *	1994-09-02	1998-11-17	Delab	Apparatus for the delivery of elongate solid drug compositions
GB9504201D0 (en) *	1995-03-02	1995-04-19	Scherer Ltd R P	Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions
DE19539574A1 (de)	1995-10-25	1997-04-30	Boehringer Mannheim Gmbh	Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) *	1995-11-03	1998-01-16	Sanofi Sa	Formulation pharmaceutique lyophilisee stable
DE69710460T2 (de) *	1996-06-17	2002-10-02	Janssen Pharmaceutica N.V., Beerse	Bikonvexe, rasch desintegrierende verabreichungsformen
JP2000512303A (ja) *	1996-06-17	2000-09-19	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	迅速に崩壊する投薬形態のマーキング
KR100823524B1 (ko) *	1996-06-17	2008-11-12	얀센 파마슈티카 엔.브이.	양쪽볼록형급속붕괴제형
KR100782897B1 (ko) *	1996-06-17	2008-04-08	얀센 파마슈티카 엔.브이.	급속붕괴제형의표시방법
GB9621614D0 (en) *	1996-10-17	1996-12-11	Cultech Limited	Vitamin delivery
GB9802088D0 (en) *	1998-01-30	1998-03-25	Scherer Ltd R P	Pharmaceutical products
US6683100B2 (en)	1999-01-19	2004-01-27	Novartis Ag	Organic compounds
US6194181B1 (en)	1998-02-19	2001-02-27	Novartis Ag	Fermentative preparation process for and crystal forms of cytostatics
ES2153229T3 (es)	1998-11-11	2001-02-16	Dalli Werke Wasche Und Korperp	Granulado densificado, procedimiento para su fabricacion y su utilizacion como agente desintegrador para cuerpos moldeados por compactacion.
US6552024B1 (en)	1999-01-21	2003-04-22	Lavipharm Laboratories Inc.	Compositions and methods for mucosal delivery
FR2828380B1 (fr) *	2001-08-10	2005-07-29	Fontarome	Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
JP2005521690A (ja)	2002-02-22	2005-07-21	ファルマシア・コーポレーション	ゴム系を含む眼科用製剤
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
AU2003262025A1 (en) *	2002-09-12	2004-04-30	Nihon Medi-Physics Co., Ltd.	Preparation for controlling binging of drug to plasma protein
US20040052853A1 (en) *	2002-09-16	2004-03-18	Cp Kelco, U.S., Inc.	Pectin films
AU2003280324A1 (en)	2002-11-26	2004-06-18	Alk-Abello A/S	Pharmaceutical allergen product
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE20321887U1 (de)	2003-11-10	2012-01-20	Allergan, Inc.	Arzneimittel umfassend niedrige Dosierungen von Desmopressin
CA2545194C (en)	2003-11-10	2014-10-21	Seymour H. Fein	Pharmaceutical compositions including low dosages of desmopressin
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
WO2006035969A1 (ja)	2004-09-28	2006-04-06	Senju Pharmaceutical Co., Ltd.	キサンタンガムおよびアミノ酸を含有する眼科用組成物
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de)	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
EP2156842A4 (en) *	2007-06-01	2013-01-23	Kyowa Hakko Bio Co Ltd	ORAL COMPOSITION
BRPI0906467C1 (pt)	2008-01-25	2021-05-25	Gruenenthal Gmbh	forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
CN102123701B (zh)	2008-05-09	2013-03-27	格吕伦塔尔有限公司	使用喷雾冻凝步骤制备中间粉末制剂以及最终固体剂型的方法
HUE042987T2 (hu)	2009-07-22	2019-07-29	Gruenenthal Gmbh	Visszaéléssel szemben ellenálló adagolási forma oxidációra érzékeny opioidok számára
BR112012001547A2 (pt)	2009-07-22	2016-03-08	Gruenenthal Gmbh	forma de dosagem farmacêutica extrusada por fusão a quente
NO2493457T3 (zh) *	2009-10-30	2018-01-06
US12186426B2 (en)	2009-10-30	2025-01-07	Ix Biopharma Ltd.	Solid dosage form
ES2486791T3 (es)	2010-09-02	2014-08-19	Grünenthal GmbH	Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
EP2611425B1 (en)	2010-09-02	2014-07-02	Grünenthal GmbH	Tamper resistant dosage form comprising an anionic polymer
US10201502B2 (en)	2011-07-29	2019-02-12	Gruenenthal Gmbh	Tamper-resistant tablet providing immediate drug release
JP6063462B2 (ja)	2011-07-29	2017-01-18	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	即時薬剤放出を提供するタンパーレジスタント錠剤
AU2013225106B2 (en)	2012-02-28	2017-11-02	Grunenthal Gmbh	Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
CA2868142A1 (en)	2012-04-18	2013-10-24	Grunenthal Gmbh	Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP3003279A1 (en)	2013-05-29	2016-04-13	Grünenthal GmbH	Tamper-resistant dosage form containing one or more particles
US9737490B2 (en)	2013-05-29	2017-08-22	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile
US10624862B2 (en)	2013-07-12	2020-04-21	Grünenthal GmbH	Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en)	2013-11-26	2020-05-28	Grunenthal Gmbh	Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9468606B2 (en) *	2014-03-31	2016-10-18	Johnson & Johnson Consumer Inc.	Compostions and methods for enhancing the topical application of an acidic benefit agent
WO2015173195A1 (en)	2014-05-12	2015-11-19	Grünenthal GmbH	Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (ja)	2014-05-26	2017-06-22	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	エタノール過量放出に対して防護されている多粒子
US20160310429A1 (en)	2015-04-24	2016-10-27	Grünenthal GmbH	Tamper-resistant dosage form with immediate release and resistance against solvent extraction
EP3346991A1 (en)	2015-09-10	2018-07-18	Grünenthal GmbH	Protecting oral overdose with abuse deterrent immediate release formulations
CN116481290A (zh) *	2022-12-28	2023-07-25	常州兰陵制药有限公司	葡萄糖酸钙结晶干燥装置及方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2166074A (en)	1937-04-09	1939-07-11	Sharp & Dohme Inc	Gelatinous colloids
GB698767A (en)	1950-07-06	1953-10-21	Bayer Ag	Readily soluble dry preparations of swelling substances
US2758644A (en) *	1953-07-30	1956-08-14	Virlouvet Jacques	Control system for slatted roller blinds
US3234091A (en)	1955-07-08	1966-02-08	Ciba Geigy Corp	Shaped medicaments and process for their manufacture
DE2017373A1 (de)	1969-04-15	1971-04-22	Orsymonde S A , Paris	Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en)	1976-10-06	1979-07-04	Wyeth John & Brother Ltd	Pharmaceutial dosage forms
CA1097233A (en)	1977-07-20	1981-03-10	George K. E. Gregory	Packages
JPS5913887B2 (ja)	1979-10-30	1984-04-02	株式会社ブリヂストン	溶融金属用濾過材
DE3404382A1 (de)	1984-02-08	1985-08-14	Anton Dr. 4400 Münster Härle	Saugflasche zum absaugen von sekreten aus wundhoehlen
US4697630A (en) *	1987-03-17	1987-10-06	General Clutch Corporation	Tilt mechanism for venetian blinds
US5079018A (en)	1989-08-14	1992-01-07	Neophore Technologies, Inc.	Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en)	1989-12-22	1993-06-01	Gole Dilip J	Preparation of pharmaceutical and other matrix systems by solid-state dissolution

1993
- 1993-04-29 IL IL105553A patent/IL105553A/en not_active IP Right Cessation
- 1993-05-03 SG SG1996001213A patent/SG47430A1/en unknown
- 1993-05-03 RO RO94-01770A patent/RO112990B1/ro unknown
- 1993-05-03 DE DE69326063T patent/DE69326063T2/de not_active Expired - Lifetime
- 1993-05-03 CA CA002135062A patent/CA2135062C/en not_active Expired - Lifetime
- 1993-05-03 AT AT93911039T patent/ATE183387T1/de active
- 1993-05-03 DK DK93911039T patent/DK0642334T3/da active
- 1993-05-03 WO PCT/US1993/004201 patent/WO1993023017A1/en active IP Right Grant
- 1993-05-03 NZ NZ252526A patent/NZ252526A/xx not_active IP Right Cessation
- 1993-05-03 PL PL93305975A patent/PL172354B1/pl unknown
- 1993-05-03 JP JP6503621A patent/JPH07508019A/ja not_active Withdrawn
- 1993-05-03 RU RU94046029A patent/RU2131244C1/ru active
- 1993-05-03 CZ CZ942654A patent/CZ283882B6/cs not_active IP Right Cessation
- 1993-05-03 HU HU9403190A patent/HU227532B1/hu unknown
- 1993-05-03 KR KR1019940703516A patent/KR100194241B1/ko not_active Expired - Lifetime
- 1993-05-03 ES ES93911039T patent/ES2136662T3/es not_active Expired - Lifetime
- 1993-05-03 EP EP93911039A patent/EP0642334B1/en not_active Expired - Lifetime
- 1993-05-03 SK SK1320-94A patent/SK280129B6/sk not_active IP Right Cessation
- 1993-05-04 MY MYPI93000832A patent/MY112231A/en unknown
- 1993-05-06 CN CN93106967A patent/CN1085081A/zh active Pending
- 1993-06-09 TW TW082104563A patent/TW380053B/zh not_active IP Right Cessation
1994
- 1994-11-03 BG BG99158A patent/BG62681B1/bg unknown
- 1994-11-04 FI FI945198A patent/FI111333B/fi not_active IP Right Cessation
- 1994-11-04 NO NO944207A patent/NO308065B1/no not_active IP Right Cessation
1995
- 1995-06-27 HU HU95P/P00465P patent/HU211549A9/hu unknown
1998
- 1998-10-29 HK HK98111598A patent/HK1010693A1/xx not_active IP Right Cessation
1999
- 1999-09-08 GR GR990402273T patent/GR3031180T3/el unknown
2000
- 2000-06-16 CY CY0000026A patent/CY2175B1/xx unknown
2004
- 2004-05-20 CL CL200401180A patent/CL2004001180A1/es unknown

Also Published As

Publication number	Publication date
CZ283882B6 (cs)	1998-06-17
RU2131244C1 (ru)	1999-06-10
KR950700728A (ko)	1995-02-20
ES2136662T3 (es)	1999-12-01
CA2135062C (en)	1999-05-25
NO944207L (no)	1994-11-04
CL2004001180A1 (es)	2005-06-03
AU4232293A (en)	1993-12-13
BG99158A (bg)	1995-05-31
FI945198A0 (fi)	1994-11-04
CZ265494A3 (en)	1995-02-15
SG47430A1 (en)	1998-04-17
FI111333B (fi)	2003-07-15
SK280129B6 (sk)	1999-08-06
HK1010693A1 (en)	1999-06-25
CY2175B1 (en)	2002-08-23
ATE183387T1 (de)	1999-09-15
TW380053B (en)	2000-01-21
HU227532B1 (en)	2011-07-28
WO1993023017A1 (en)	1993-11-25
NO308065B1 (no)	2000-07-17
DK0642334T3 (da)	2000-04-17
DE69326063D1 (de)	1999-09-23
AU677198B2 (en)	1997-04-17
MY112231A (en)	2001-05-31
SK132094A3 (en)	1995-07-11
KR100194241B1 (ko)	1999-06-15
IL105553A0 (en)	1993-08-18
CA2135062A1 (en)	1993-11-25
RU94046029A (ru)	1996-11-10
HUT68224A (en)	1995-06-28
CN1085081A (zh)	1994-04-13
EP0642334B1 (en)	1999-08-18
DE69326063T2 (de)	2000-03-16
GR3031180T3 (en)	1999-12-31
NZ252526A (en)	1995-09-26
EP0642334A1 (en)	1995-03-15
JPH07508019A (ja)	1995-09-07
PL172354B1 (pl)	1997-09-30
RO112990B1 (ro)	1998-03-30
NO944207D0 (no)	1994-11-04
BG62681B1 (bg)	2000-05-31
HU211549A9 (en)	1995-12-28
FI945198L (fi)	1994-11-04

Publication	Publication Date	Title
US5558880A (en)	1996-09-24	Pharmaceutical and other dosage forms
RU2131244C1 (ru)	1999-06-10	Твердая дозированная форма
US5215756A (en)	1993-06-01	Preparation of pharmaceutical and other matrix systems by solid-state dissolution
JP4943581B2 (ja)	2012-05-30	迅速分散性固形経口投与用剤形の製造方法
EP0701815B1 (de)	1999-06-30	Verfahren zur Herstellung von Wirkstoff enthaltenden Pulvern, Granulaten oder Pellets mit einem Gerüst aus hydrophilen Makromolekülen und ihre Verwendung
JP3233638B2 (ja)	2001-11-26	凍結乾燥された薬投与形状物の製造方法
US6090401A (en)	2000-07-18	Stable foam composition
FR2702968A1 (fr)	1994-09-30	Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
AU677198C (en)	1997-12-04	Pharmaceutical and other dosage forms
CA2128242C (en)	1998-09-22	Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets
IE904520A1 (en)	1991-07-03	Preparation of pharmaceutical and other matrix systems by¹solid-state dissolution

Legal Events

Date	Code	Title
1998-06-15	FF	Patent granted
1998-11-26	KB	Patent renewed
1999-10-28	KB	Patent renewed
2003-06-24	KB	Patent renewed
2007-07-06	KB	Patent renewed
2011-05-31	KB	Patent renewed
2013-12-31	EXP	Patent expired